JP2024515880A5 - - Google Patents
Info
- Publication number
- JP2024515880A5 JP2024515880A5 JP2023566873A JP2023566873A JP2024515880A5 JP 2024515880 A5 JP2024515880 A5 JP 2024515880A5 JP 2023566873 A JP2023566873 A JP 2023566873A JP 2023566873 A JP2023566873 A JP 2023566873A JP 2024515880 A5 JP2024515880 A5 JP 2024515880A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- active
- composition
- composition according
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182605P | 2021-04-30 | 2021-04-30 | |
| US63/182,605 | 2021-04-30 | ||
| PCT/US2022/026998 WO2022232552A1 (en) | 2021-04-30 | 2022-04-29 | Lipid nanoparticle therapeutics that evade the immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515880A JP2024515880A (ja) | 2024-04-10 |
| JP2024515880A5 true JP2024515880A5 (cg-RX-API-DMAC7.html) | 2025-05-09 |
Family
ID=83848676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566873A Pending JP2024515880A (ja) | 2021-04-30 | 2022-04-29 | 免疫応答を回避する脂質ナノ粒子治療薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240226310A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4329816A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024515880A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117425496A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022264032A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3217121A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022232552A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260094503A (ko) * | 2023-09-13 | 2026-06-22 | 테세라 테라퓨틱스, 인크. | 치료용 페이로드를 세포에 전달하기 위한 지질 나노입자 |
| WO2025129106A1 (en) * | 2023-12-14 | 2025-06-19 | The Trustees Of The University Of Pennsylvania | Immunoevasive targeting molecules for efficient targeted delivery |
| WO2025166993A1 (zh) * | 2024-02-05 | 2025-08-14 | 复旦大学 | 一种新型脂质化合物以及组合物和核酸脂质纳米颗粒制剂及其筛选方法和应用 |
| WO2026122996A1 (en) * | 2024-12-06 | 2026-06-11 | Tessera Therapeutics, Inc. | Lipid nanoparticles for delivery of therapeutic payloads to cells |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10258698B2 (en) * | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| WO2016145031A1 (en) * | 2015-03-09 | 2016-09-15 | Stc.Unm | Cd 47 containing porous nanoparticle supported lipid bilayers (protocells) |
| EA201890006A1 (ru) * | 2015-06-10 | 2018-05-31 | Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем | Применение экзосом для лечения болезни |
| WO2017106380A1 (en) * | 2015-12-18 | 2017-06-22 | The Regents Of The University Of California | Protein nanocapsules with detachable zwitterionic coating for protein delivery |
| US20190046446A1 (en) * | 2016-09-30 | 2019-02-14 | Eriochem Usa, Llc | Apo-e modified lipid nanoparticles for drug delivery to targeted tissues and therapeutic methods |
| AU2019255765B2 (en) * | 2018-04-19 | 2025-02-06 | Board Of Regents, The University Of Texas System | Therapeutic modulation of tumor suppressors using exosomes |
| CN110878127B (zh) * | 2018-09-06 | 2022-06-28 | 浙江柏拉阿图医药科技有限公司 | 长效重组GLP1-Fc-CD47蛋白及其制备和用途 |
| US20200093936A1 (en) * | 2018-09-21 | 2020-03-26 | The Trustees Of The University Of Pennsylvania | Therapeutic Targeting of Lipid Nanoparticles |
| CN110540589B (zh) * | 2019-01-08 | 2021-07-20 | 西南大学 | 一种多肽、多肽修饰的脂质载体及应用 |
| US20220251200A1 (en) * | 2019-07-03 | 2022-08-11 | Codiak Biosciences, Inc. | Extracellular vesicles targeting t cells and uses thereof |
-
2022
- 2022-04-29 CN CN202280038633.4A patent/CN117425496A/zh active Pending
- 2022-04-29 AU AU2022264032A patent/AU2022264032A1/en active Pending
- 2022-04-29 WO PCT/US2022/026998 patent/WO2022232552A1/en not_active Ceased
- 2022-04-29 JP JP2023566873A patent/JP2024515880A/ja active Pending
- 2022-04-29 CA CA3217121A patent/CA3217121A1/en active Pending
- 2022-04-29 EP EP22796834.4A patent/EP4329816A4/en active Pending
- 2022-04-29 US US18/558,013 patent/US20240226310A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5914356B2 (ja) | インターフェロンアナログ | |
| Bansal et al. | Novel engineered targeted interferon‐gamma blocks hepatic fibrogenesis in mice | |
| ES2744225T3 (es) | Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos | |
| JP6416106B2 (ja) | ゴナドトロピンカルボキシ末端ペプチドに結合することによりポリペプチドの流体力学的体積を増加させる方法 | |
| US8802240B2 (en) | Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells | |
| US20160199309A1 (en) | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof | |
| Guichard et al. | PEGylation, an approach for improving the pulmonary delivery of biopharmaceuticals | |
| JP2009519011A5 (cg-RX-API-DMAC7.html) | ||
| JP2009518025A5 (cg-RX-API-DMAC7.html) | ||
| JP2012067100A (ja) | Il−21の誘導体 | |
| AU2006215566A1 (en) | Insulinotropic agents conjugated with structurally well defined branched polymers | |
| JP2025122021A5 (cg-RX-API-DMAC7.html) | ||
| JP2017503022A (ja) | インビボで細胞に活性型テロメラーゼを提供する組成物および方法 | |
| Rodríguez-Castejón et al. | Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review | |
| JP2021176875A (ja) | ポリエチレングリコール(peg)−インターロイキン11(il−11)コンジュゲートを生成するための反応中間体、および、peg−il−11コンジュゲートを精製する方法 | |
| WO2005035565A1 (en) | Il-21 derivatives | |
| US20220202903A1 (en) | Hematopoietic Growth Factor Proteins and Analogs Thereof and Angiotensin Converting Enzyme Inhibitors for Treatment of Radiation Exposure | |
| ES2372728T3 (es) | Cicatrización de heridas mediante la administración de il-18 humana. | |
| KR102685034B1 (ko) | 금속 나노 입자-핵산 결합체를 기반으로 하는 유전자 운반체 | |
| US20090054318A1 (en) | Immunopotentiating Agent | |
| CN104136038A (zh) | 体腔积液抑制剂 | |
| JPH1067678A (ja) | 肝疾患治療用医薬組成物 | |
| WO2024065651A1 (zh) | 一种向adam10基因敲除的hek293细胞外泌体中装载二聚体cd24的方法 | |
| DE10049010A1 (de) | Transferrin-Polykation/DNS-Komplexe für die systemische Therapie von Tumorerkrankungen mit zytotoxischen Proteinen | |
| WO2025176180A1 (zh) | 艾日布林衍生物药物偶联物用于治疗肿瘤的用途 |